nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—HTR1A—Parkinson's disease	0.356	0.408	CbGaD
Vilazodone—DRD2—Parkinson's disease	0.302	0.347	CbGaD
Vilazodone—CYP2D6—Parkinson's disease	0.214	0.245	CbGaD
Vilazodone—HTR1A—telencephalic ventricle—Parkinson's disease	0.00335	0.105	CbGeAlD
Vilazodone—DRD2—telencephalic ventricle—Parkinson's disease	0.00303	0.0946	CbGeAlD
Vilazodone—DRD2—nerve—Parkinson's disease	0.00191	0.0596	CbGeAlD
Vilazodone—SLC6A4—hindbrain—Parkinson's disease	0.00178	0.0556	CbGeAlD
Vilazodone—HTR1A—hindbrain—Parkinson's disease	0.00158	0.0494	CbGeAlD
Vilazodone—DRD2—hindbrain—Parkinson's disease	0.00143	0.0446	CbGeAlD
Vilazodone—SLC6A4—brainstem—Parkinson's disease	0.00102	0.0319	CbGeAlD
Vilazodone—SLC6A4—forebrain—Parkinson's disease	0.000985	0.0308	CbGeAlD
Vilazodone—HTR1A—brainstem—Parkinson's disease	0.000906	0.0283	CbGeAlD
Vilazodone—Aripiprazole—HTR7—Parkinson's disease	0.000875	0.131	CrCbGaD
Vilazodone—HTR1A—forebrain—Parkinson's disease	0.000874	0.0273	CbGeAlD
Vilazodone—CYP2D6—hindbrain—Parkinson's disease	0.000858	0.0268	CbGeAlD
Vilazodone—Aripiprazole—DRD3—Parkinson's disease	0.000823	0.123	CrCbGaD
Vilazodone—DRD2—brainstem—Parkinson's disease	0.000819	0.0256	CbGeAlD
Vilazodone—Aripiprazole—DRD1—Parkinson's disease	0.000807	0.121	CrCbGaD
Vilazodone—DRD2—forebrain—Parkinson's disease	0.00079	0.0247	CbGeAlD
Vilazodone—HTR1A—cardiovascular system—Parkinson's disease	0.000739	0.0231	CbGeAlD
Vilazodone—Aripiprazole—HTR1A—Parkinson's disease	0.000671	0.101	CrCbGaD
Vilazodone—Trazodone—HTR1A—Parkinson's disease	0.000667	0.1	CrCbGaD
Vilazodone—SLC6A4—midbrain—Parkinson's disease	0.00065	0.0203	CbGeAlD
Vilazodone—SLC6A4—spinal cord—Parkinson's disease	0.000634	0.0198	CbGeAlD
Vilazodone—HTR1A—midbrain—Parkinson's disease	0.000577	0.018	CbGeAlD
Vilazodone—Aripiprazole—DRD2—Parkinson's disease	0.000569	0.0854	CrCbGaD
Vilazodone—SLC6A4—head—Parkinson's disease	0.000564	0.0176	CbGeAlD
Vilazodone—HTR1A—spinal cord—Parkinson's disease	0.000563	0.0176	CbGeAlD
Vilazodone—SLC6A4—nervous system—Parkinson's disease	0.000535	0.0167	CbGeAlD
Vilazodone—DRD2—midbrain—Parkinson's disease	0.000522	0.0163	CbGeAlD
Vilazodone—SLC6A4—central nervous system—Parkinson's disease	0.000515	0.0161	CbGeAlD
Vilazodone—HTR1A—head—Parkinson's disease	0.000501	0.0156	CbGeAlD
Vilazodone—CYP2D6—brainstem—Parkinson's disease	0.000492	0.0154	CbGeAlD
Vilazodone—CYP2D6—forebrain—Parkinson's disease	0.000475	0.0148	CbGeAlD
Vilazodone—HTR1A—nervous system—Parkinson's disease	0.000475	0.0148	CbGeAlD
Vilazodone—HTR1A—central nervous system—Parkinson's disease	0.000457	0.0143	CbGeAlD
Vilazodone—DRD2—head—Parkinson's disease	0.000452	0.0141	CbGeAlD
Vilazodone—HTR1A—cerebellum—Parkinson's disease	0.000447	0.014	CbGeAlD
Vilazodone—Aripiprazole—HTR2A—Parkinson's disease	0.00044	0.066	CrCbGaD
Vilazodone—Trazodone—HTR2A—Parkinson's disease	0.000438	0.0657	CrCbGaD
Vilazodone—DRD2—nervous system—Parkinson's disease	0.000429	0.0134	CbGeAlD
Vilazodone—DRD2—central nervous system—Parkinson's disease	0.000413	0.0129	CbGeAlD
Vilazodone—SLC6A4—brain—Parkinson's disease	0.000409	0.0128	CbGeAlD
Vilazodone—DRD2—cerebellum—Parkinson's disease	0.000404	0.0126	CbGeAlD
Vilazodone—Aripiprazole—CYP2D6—Parkinson's disease	0.000402	0.0603	CrCbGaD
Vilazodone—Trazodone—CYP2D6—Parkinson's disease	0.0004	0.0601	CrCbGaD
Vilazodone—HTR1A—brain—Parkinson's disease	0.000363	0.0113	CbGeAlD
Vilazodone—DRD2—brain—Parkinson's disease	0.000328	0.0102	CbGeAlD
Vilazodone—Aripiprazole—ABCB1—Parkinson's disease	0.000287	0.0431	CrCbGaD
Vilazodone—Trazodone—ABCB1—Parkinson's disease	0.000286	0.0429	CrCbGaD
Vilazodone—CYP2D6—head—Parkinson's disease	0.000272	0.0085	CbGeAlD
Vilazodone—CYP3A4—nervous system—Parkinson's disease	0.000262	0.00819	CbGeAlD
Vilazodone—CYP2D6—nervous system—Parkinson's disease	0.000258	0.00806	CbGeAlD
Vilazodone—CYP3A4—central nervous system—Parkinson's disease	0.000252	0.00788	CbGeAlD
Vilazodone—CYP2D6—central nervous system—Parkinson's disease	0.000248	0.00776	CbGeAlD
Vilazodone—CYP2D6—cerebellum—Parkinson's disease	0.000242	0.00758	CbGeAlD
Vilazodone—CYP2D6—brain—Parkinson's disease	0.000197	0.00616	CbGeAlD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	7.83e-05	0.000877	CbGpPWpGaD
Vilazodone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	7.79e-05	0.000874	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD1—Parkinson's disease	7.75e-05	0.000869	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GRK5—Parkinson's disease	7.72e-05	0.000866	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	7.7e-05	0.000863	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GRM4—Parkinson's disease	7.62e-05	0.000855	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.59e-05	0.000851	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD3—Parkinson's disease	7.5e-05	0.000842	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	7.46e-05	0.000837	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	7.4e-05	0.00083	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	7.29e-05	0.000817	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VPS35—Parkinson's disease	7.26e-05	0.000814	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PENK—Parkinson's disease	7.23e-05	0.00081	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.14e-05	0.0008	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	7.04e-05	0.00079	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—MAPK8—Parkinson's disease	6.94e-05	0.000778	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	6.94e-05	0.000778	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GRM4—Parkinson's disease	6.92e-05	0.000776	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	6.8e-05	0.000763	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR7—Parkinson's disease	6.79e-05	0.000761	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—DRD2—Parkinson's disease	6.79e-05	0.000761	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	6.78e-05	0.00076	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—DDC—Parkinson's disease	6.73e-05	0.000755	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	6.73e-05	0.000754	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	6.69e-05	0.000751	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PDYN—Parkinson's disease	6.61e-05	0.000741	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	6.59e-05	0.000739	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PENK—Parkinson's disease	6.56e-05	0.000736	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.46e-05	0.000724	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.44e-05	0.000722	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	6.4e-05	0.000717	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—COMT—Parkinson's disease	6.38e-05	0.000715	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VPS35—Parkinson's disease	6.38e-05	0.000715	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTA4—Parkinson's disease	6.36e-05	0.000713	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	6.35e-05	0.000712	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	6.35e-05	0.000712	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	6.33e-05	0.00071	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	6.29e-05	0.000705	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	6.26e-05	0.000703	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	6.26e-05	0.000702	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.24e-05	0.0007	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	6.15e-05	0.000689	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	6.08e-05	0.000682	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	6.02e-05	0.000675	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	6.02e-05	0.000675	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	6e-05	0.000673	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	5.96e-05	0.000668	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	5.83e-05	0.000654	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	5.8e-05	0.000651	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PENK—Parkinson's disease	5.76e-05	0.000646	CbGpPWpGaD
Vilazodone—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	5.75e-05	0.000645	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PLA2G6—Parkinson's disease	5.72e-05	0.000642	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MAOB—Parkinson's disease	5.67e-05	0.000635	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	5.58e-05	0.000626	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	5.5e-05	0.000617	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	5.5e-05	0.000617	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	5.48e-05	0.000615	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	5.43e-05	0.000609	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.43e-05	0.000609	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.43e-05	0.000608	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	5.4e-05	0.000605	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	5.28e-05	0.000592	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GPR37—Parkinson's disease	5.28e-05	0.000592	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	5.27e-05	0.000591	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.23e-05	0.000586	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.03e-05	0.000564	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.96e-05	0.000556	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	4.9e-05	0.000549	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	4.83e-05	0.000542	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	4.81e-05	0.000539	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	4.77e-05	0.000535	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	4.75e-05	0.000533	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	4.75e-05	0.000532	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.69e-05	0.000525	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.59e-05	0.000514	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	4.56e-05	0.000511	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	4.47e-05	0.000501	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	4.43e-05	0.000497	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	4.38e-05	0.000491	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	4.24e-05	0.000476	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	4.24e-05	0.000476	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RIT2—Parkinson's disease	4.22e-05	0.000474	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP2D6—Parkinson's disease	4.21e-05	0.000472	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	4.17e-05	0.000468	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.17e-05	0.000467	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	4.17e-05	0.000467	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.15e-05	0.000465	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.14e-05	0.000464	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ND3—Parkinson's disease	4.13e-05	0.000464	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.13e-05	0.000464	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CTGF—Parkinson's disease	4.13e-05	0.000463	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.11e-05	0.000461	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.09e-05	0.000459	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	4.09e-05	0.000459	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	4.06e-05	0.000455	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRK5—Parkinson's disease	4e-05	0.000449	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.98e-05	0.000446	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	3.98e-05	0.000446	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.96e-05	0.000444	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	3.92e-05	0.00044	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—OMD—Parkinson's disease	3.89e-05	0.000436	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.89e-05	0.000436	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PENK—Parkinson's disease	3.88e-05	0.000435	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAG—Parkinson's disease	3.88e-05	0.000435	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	3.85e-05	0.000432	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP2E1—Parkinson's disease	3.85e-05	0.000432	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	3.84e-05	0.000431	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	3.84e-05	0.00043	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	3.84e-05	0.00043	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.81e-05	0.000428	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NQO1—Parkinson's disease	3.81e-05	0.000427	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.78e-05	0.000424	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.76e-05	0.000422	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—TH—Parkinson's disease	3.75e-05	0.000421	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	3.72e-05	0.000418	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.69e-05	0.000413	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	3.62e-05	0.000405	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYCS—Parkinson's disease	3.6e-05	0.000404	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.6e-05	0.000403	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRM4—Parkinson's disease	3.59e-05	0.000403	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	3.56e-05	0.000399	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	3.55e-05	0.000398	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.52e-05	0.000394	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	3.49e-05	0.000392	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	3.48e-05	0.000391	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	3.48e-05	0.000391	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.48e-05	0.00039	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PENK—Parkinson's disease	3.4e-05	0.000382	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAG—Parkinson's disease	3.4e-05	0.000382	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	3.38e-05	0.000379	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	3.37e-05	0.000378	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	3.33e-05	0.000374	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	3.3e-05	0.00037	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—COMT—Parkinson's disease	3.19e-05	0.000358	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTP1—Parkinson's disease	3.18e-05	0.000356	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MAOA—Parkinson's disease	3.17e-05	0.000355	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	3.16e-05	0.000354	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GBA—Parkinson's disease	3.13e-05	0.000351	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.13e-05	0.000351	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DBH—Parkinson's disease	3.13e-05	0.000351	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HMOX1—Parkinson's disease	3.13e-05	0.000351	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDYN—Parkinson's disease	3.11e-05	0.000349	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	3.07e-05	0.000344	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	3.06e-05	0.000343	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ABCB1—Parkinson's disease	3.01e-05	0.000337	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.93e-05	0.000328	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTM1—Parkinson's disease	2.92e-05	0.000327	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.89e-05	0.000325	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	2.89e-05	0.000324	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.8e-05	0.000314	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GPX1—Parkinson's disease	2.79e-05	0.000313	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	2.79e-05	0.000313	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	2.71e-05	0.000304	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.7e-05	0.000303	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ND3—Parkinson's disease	2.7e-05	0.000303	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	2.7e-05	0.000302	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.69e-05	0.000301	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INSR—Parkinson's disease	2.59e-05	0.00029	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—Parkinson's disease	2.58e-05	0.000289	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—OMD—Parkinson's disease	2.54e-05	0.000285	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.54e-05	0.000285	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF20—Parkinson's disease	2.54e-05	0.000285	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	2.46e-05	0.000276	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	2.45e-05	0.000275	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGB—Parkinson's disease	2.45e-05	0.000274	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	2.44e-05	0.000274	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.41e-05	0.00027	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOE—Parkinson's disease	2.4e-05	0.000269	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	2.4e-05	0.000269	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.36e-05	0.000264	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	2.35e-05	0.000263	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DDC—Parkinson's disease	2.3e-05	0.000258	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.3e-05	0.000258	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	2.28e-05	0.000255	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INSR—Parkinson's disease	2.27e-05	0.000255	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.17e-05	0.000244	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGB—Parkinson's disease	2.15e-05	0.000241	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	2.14e-05	0.00024	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	2.14e-05	0.000239	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	2.12e-05	0.000238	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TAC1—Parkinson's disease	2.1e-05	0.000236	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD1—Parkinson's disease	2.06e-05	0.000231	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	2.06e-05	0.000231	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	2.06e-05	0.000231	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—INS—Parkinson's disease	2.05e-05	0.00023	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DBH—Parkinson's disease	2.05e-05	0.00023	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.05e-05	0.00023	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GBA—Parkinson's disease	2.05e-05	0.00023	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD3—Parkinson's disease	2e-05	0.000224	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.96e-05	0.000219	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.94e-05	0.000217	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.87e-05	0.000209	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.81e-05	0.000203	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.72e-05	0.000193	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.67e-05	0.000187	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.65e-05	0.000185	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.51e-05	0.00017	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.51e-05	0.00017	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DDC—Parkinson's disease	1.5e-05	0.000169	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.46e-05	0.000164	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.45e-05	0.000162	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.44e-05	0.000162	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.42e-05	0.000159	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.41e-05	0.000158	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—Parkinson's disease	1.34e-05	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.33e-05	0.000149	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.32e-05	0.000148	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.3e-05	0.000146	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TH—Parkinson's disease	1.28e-05	0.000144	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.28e-05	0.000143	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.27e-05	0.000142	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.27e-05	0.000142	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.23e-05	0.000138	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.18e-05	0.000132	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INS—Parkinson's disease	1.14e-05	0.000128	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—COMT—Parkinson's disease	1.09e-05	0.000122	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.09e-05	0.000122	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.08e-05	0.000121	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.07e-05	0.00012	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.03e-05	0.000115	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INS—Parkinson's disease	1e-05	0.000113	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	9.97e-06	0.000112	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GPX1—Parkinson's disease	9.55e-06	0.000107	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.41e-06	0.000105	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.23e-06	0.000104	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	8.81e-06	9.88e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.6e-06	9.65e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	8.52e-06	9.56e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.51e-06	9.54e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	8.47e-06	9.49e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TH—Parkinson's disease	8.38e-06	9.4e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—Parkinson's disease	8.21e-06	9.2e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.05e-06	9.03e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	7.83e-06	8.78e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—Parkinson's disease	7.48e-06	8.39e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—Parkinson's disease	7.43e-06	8.33e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—COMT—Parkinson's disease	7.13e-06	7.99e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.1e-06	7.96e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.08e-06	7.94e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INS—Parkinson's disease	7.01e-06	7.86e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7e-06	7.85e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	6.88e-06	7.71e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.72e-06	7.53e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.52e-06	7.31e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.24e-06	7e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.76e-06	6.46e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—Parkinson's disease	5.36e-06	6.02e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—Parkinson's disease	5e-06	5.61e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INS—Parkinson's disease	4.58e-06	5.14e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—Parkinson's disease	4.39e-06	4.92e-05	CbGpPWpGaD
